Cargando…

New-onset COVID-19–related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection

OBJECTIVE: The pandemic of 2019 coronavirus (SARS-CoV-2) disease (COVID-19) has imposed a severe public health burden worldwide. Most patients with COVID-19 were mild. Severe patients progressed rapidly to critical condition including acute respiratory distress syndrome (ARDS), multi-organ failure a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jin-Kui, Zhao, Miao-Miao, Jin, Jian-Min, Liu, Shi, Bai, Peng, He, Wei, Wu, Fei, Liu, Xiao-Fang, Chai, Zhong-Lin, Han, De-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132601/
https://www.ncbi.nlm.nih.gov/pubmed/35673632
http://dx.doi.org/10.1007/s44194-022-00006-x
_version_ 1784713414418890752
author Yang, Jin-Kui
Zhao, Miao-Miao
Jin, Jian-Min
Liu, Shi
Bai, Peng
He, Wei
Wu, Fei
Liu, Xiao-Fang
Chai, Zhong-Lin
Han, De-Min
author_facet Yang, Jin-Kui
Zhao, Miao-Miao
Jin, Jian-Min
Liu, Shi
Bai, Peng
He, Wei
Wu, Fei
Liu, Xiao-Fang
Chai, Zhong-Lin
Han, De-Min
author_sort Yang, Jin-Kui
collection PubMed
description OBJECTIVE: The pandemic of 2019 coronavirus (SARS-CoV-2) disease (COVID-19) has imposed a severe public health burden worldwide. Most patients with COVID-19 were mild. Severe patients progressed rapidly to critical condition including acute respiratory distress syndrome (ARDS), multi-organ failure and even death. This study aims to find early multi-organ injury indicators and blood glucose for predicting mortality of COVID-19. METHODS: Fasting blood glucose (FBG) ≥7.0 mmol/L for two times during hospitalization and without a history of diabetes were defined as new-onset COVID-19-related diabetes (CRD). Indicators of injuries for multiple organs, including the lung, heart, kidney and liver, and glucose homeostasis were specifically analyzed for predicting death. RESULTS: A total of 120 patients with a severity equal to or greater than Moderate were hospitalized. After excluding patients with history of diabetes, chronic heart, kidney, and liver disease, 69 patients were included in the final analysis. Of the 69 patients, 23 were Moderate, 20 were Severe, and 26 were Critical (including 16 deceased patients). Univariable analysis indicated that CRD, lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBDH), creatine kinase (CK) and creatinine (Cr) were associated with death. Multivariable analysis indicated that CRD was an independent predictor for death (HR = 3.75, 95% CI 1.26–11.15). Abnormal glucose homeostasis or CRD occurred earlier than other indicators for predicting poor outcomes. Indicators of multiple organ injury were in parallel with the expression patterns of ACE2 (the SARS-CoV-2 receptor) in different organs including pancreatic islet. CONCLUSIONS: New-onset COVID-19-related diabetes is an early indicator of multi-organ injury and predictor for poor outcomes and death in COVID-19 patients. As it is easy to perform for clinical practices and self-monitoring, glucose testing will be helpful for predicting poor outcomes to facilitate appropriate intensive care.
format Online
Article
Text
id pubmed-9132601
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Nature Singapore
record_format MEDLINE/PubMed
spelling pubmed-91326012022-05-26 New-onset COVID-19–related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection Yang, Jin-Kui Zhao, Miao-Miao Jin, Jian-Min Liu, Shi Bai, Peng He, Wei Wu, Fei Liu, Xiao-Fang Chai, Zhong-Lin Han, De-Min Curr Med Original Research OBJECTIVE: The pandemic of 2019 coronavirus (SARS-CoV-2) disease (COVID-19) has imposed a severe public health burden worldwide. Most patients with COVID-19 were mild. Severe patients progressed rapidly to critical condition including acute respiratory distress syndrome (ARDS), multi-organ failure and even death. This study aims to find early multi-organ injury indicators and blood glucose for predicting mortality of COVID-19. METHODS: Fasting blood glucose (FBG) ≥7.0 mmol/L for two times during hospitalization and without a history of diabetes were defined as new-onset COVID-19-related diabetes (CRD). Indicators of injuries for multiple organs, including the lung, heart, kidney and liver, and glucose homeostasis were specifically analyzed for predicting death. RESULTS: A total of 120 patients with a severity equal to or greater than Moderate were hospitalized. After excluding patients with history of diabetes, chronic heart, kidney, and liver disease, 69 patients were included in the final analysis. Of the 69 patients, 23 were Moderate, 20 were Severe, and 26 were Critical (including 16 deceased patients). Univariable analysis indicated that CRD, lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBDH), creatine kinase (CK) and creatinine (Cr) were associated with death. Multivariable analysis indicated that CRD was an independent predictor for death (HR = 3.75, 95% CI 1.26–11.15). Abnormal glucose homeostasis or CRD occurred earlier than other indicators for predicting poor outcomes. Indicators of multiple organ injury were in parallel with the expression patterns of ACE2 (the SARS-CoV-2 receptor) in different organs including pancreatic islet. CONCLUSIONS: New-onset COVID-19-related diabetes is an early indicator of multi-organ injury and predictor for poor outcomes and death in COVID-19 patients. As it is easy to perform for clinical practices and self-monitoring, glucose testing will be helpful for predicting poor outcomes to facilitate appropriate intensive care. Springer Nature Singapore 2022-05-26 2022 /pmc/articles/PMC9132601/ /pubmed/35673632 http://dx.doi.org/10.1007/s44194-022-00006-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Research
Yang, Jin-Kui
Zhao, Miao-Miao
Jin, Jian-Min
Liu, Shi
Bai, Peng
He, Wei
Wu, Fei
Liu, Xiao-Fang
Chai, Zhong-Lin
Han, De-Min
New-onset COVID-19–related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection
title New-onset COVID-19–related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection
title_full New-onset COVID-19–related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection
title_fullStr New-onset COVID-19–related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection
title_full_unstemmed New-onset COVID-19–related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection
title_short New-onset COVID-19–related diabetes: an early indicator of multi-organ injury and mortally of SARS-CoV-2 infection
title_sort new-onset covid-19–related diabetes: an early indicator of multi-organ injury and mortally of sars-cov-2 infection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132601/
https://www.ncbi.nlm.nih.gov/pubmed/35673632
http://dx.doi.org/10.1007/s44194-022-00006-x
work_keys_str_mv AT yangjinkui newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT zhaomiaomiao newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT jinjianmin newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT liushi newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT baipeng newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT hewei newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT wufei newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT liuxiaofang newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT chaizhonglin newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection
AT handemin newonsetcovid19relateddiabetesanearlyindicatorofmultiorganinjuryandmortallyofsarscov2infection